Description
This new report from Kalorama Information is designed to provide an overview of the IVD market in India and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:
- Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing.
- Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza)
- Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
- Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases. Also includes POC and non-POC blood gas and electrolytes. Also includes glucose self-monitoring tests.
- Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.
All market data pertains to the Indian IVD market at the manufacturers’ level. Market data is presented for the 2021 year with forecast data provided for 2026. Compound annual growth rates (CAGRs) are provided for the 2021-2026 period.
Table of Contents
Chapter 1: Executive Summary
Industry Overview
Scope and Methodology
Indian IVD Market Summary
- Figure 1-1: India In Vitro Diagnostic Sales by Market Segment, 2021-2026 ($ millions)
Chapter 2: India Overview
Population
- Table 2-1: Total Midyear Population by Broad Age Group: India (million persons), 2010-2060
- Figure 2-1: Total Midyear Population by Broad Age Group: India (million persons), 2010-2060
- Figure 2-2: Total Number of Births in India by Year, 1990-2020
- Figure 2-3: India Life Expectancy at Birth in Years, 2000-2100
Health Indicators
General Health
Disease Profiles in India
- Table 2-2: Top 5 Cancers Affecting Indian Population (ranked by total number of cases), 2020
Economy and Health Spending
- Figure 2-4: India GDP, GDP (PPP) and Health Spending, 1990-2020 (billions of $)
- Figure 2-5: India Real GDP Growth, Inflation Rate (consumer prices) 2017-2020
Health Infrastructure
Medical Facilities
Hospital Bed Density
- Figure 2-6: Hospital Bed Density per 1,000 Population by Country, 2020 Estimates
Physicians and Health Professionals
- Figure 2-7: Physician Density per 1,000 Population by Country, 2020 Estimates
Medical Device Regulation
Chapter 3: IVD Markets in India
Market Summary
- Table 3-1: India In Vitro Diagnostic Sales by Extracted Market Segment, 2021-2026 ($ millions)
- Figure 3-1: India In Vitro Diagnostic Sales by Broad Market Segment, 2021 – 2026 ($ millions)
- Figure 3-2: India In Vitro Diagnostic Sales by Broad Market Segment, 2021 Market Distribution (%)
Clinical Chemistry, Hematology, Coagulation
- Figure 3-3: India – Clinical Chemistry (General Chemistries, Blood Gas Analysis, Urinalysis), Hematology, Coagulation Market, 2021 – 2026 ($ millions)
Immunoassay
- Figure 3-4: India – Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2021 – 2026 ($ millions)
Microbiology/Molecular
- Figure 3-5: India – Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2021 – 2026 ($ millions)
Point-of-Care
- Figure 3-6: India – POC Market Value by Segment (Glucose, Infectious Disease, Others), 2021 – 2026 ($ millions)
Histology
- Figure 3-7: India – Histology Market (HPV, CTC, Others), 2021 – 2026 ($ millions)
Chapter 4: Company Profiles
Abbott India Limited
- Table 4-1: Abbott India Summary
Company Overview
Product News
Performance Review
- Table 4-2: Abbott Revenues 2019-2021 (in millions $)
Becton Dickinson (BD) India
- Table 4-3: BD India Summary
Company Overview
Product News
Performance Review
- Table 4-4: BD Corporation Revenue (2019-2021 ($ millions)
bioMérieux India Private Limited
- Table 4-5: bioMérieux India Corporate Summary
Company Overview
Product News
Performance Review
- Table 4-6 : bioMérieux Revenues (2019-2021) ($ millions)
Bio-Rad Laboratories India Private Limited
- Table 4-7: Bio-Rad Labs India Summary
Company Overview
Product News
Performance Review
- Table 4-8: Bio-Rad Corporation Revenue (2019-2021) ($ millions)
Danaher Corporation India
- Table 4-9: Danaher India Summary
Company Overview
Product News
Performance Review
- Table 4-10 Danaher Revenue (2019-2021) ($ millions)
Fujifilm India Private Limited
- Table 4-11: Fujifilm India Summary
Company Overview
Product News
Performance Review
- Table 4-12: Fujifilm (2019-2021) ($ billions)
QIAGEN India Pvt. Ltd
- Table 4-13: QIAGEN India Summary
Company Overview
Product News
Performance Review
- Table 4-14: QAIGEN 2019-2021) ($ millions)
Roche India
- Table 4-15: Roche India Corporate Summary
Company Overview
Product News
Performance Review
- Table 4-16: Roche Diagnostics (2019-2021) ($ millions)
Siemens Healthcare Private Limited
- Table 4-17: Siemens Healthineers Corporate Summary
Company Overview
Product News
Performance Review
- Table 4-18: Siemens Healthineers (2019-2021) ($ millions)
Sysmex India Pvt Ltd.
- Table 4-19: Sysmex India Summary
Company Overview
Product News
Performance Review
- Table 4-20: Sysmex (2019-2021) ($ millions)
Thermo Fisher Scientific India Pvt. Ltd.
- Table 4-21: Thermo Fisher India Summary
Company Overview
Product News
Performance Review
- Table 4-22: Thermo Fisher (2019-2021) ($ millions)
Transasia Bio-Medical
- Table 4-23: TransAsia Bio-Medical Summary
Company Overview
Product News
